2023 Q4 Form 10-Q Financial Statement

#000084914623000204 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $51.62M $51.36M
YoY Change -3.8% -0.79%
Cost Of Revenue $11.07M $10.18M
YoY Change -5.89% 2.39%
Gross Profit $40.56M $41.18M
YoY Change -3.21% -1.55%
Gross Profit Margin 78.56% 80.18%
Selling, General & Admin $20.07M $17.96M
YoY Change 2.48% 7.37%
% of Gross Profit 49.47% 43.61%
Research & Development $100.0K $200.0K
YoY Change -50.0% 100.0%
% of Gross Profit 0.25% 0.49%
Depreciation & Amortization $960.0K $918.0K
YoY Change -0.83% 9.16%
% of Gross Profit 2.37% 2.23%
Operating Expenses $41.82M $40.44M
YoY Change -3.05% -0.26%
Operating Profit -$1.261M $749.0K
YoY Change 2.35% -41.94%
Interest Expense $145.0K $70.00K
YoY Change -37.5%
% of Operating Profit 9.35%
Other Income/Expense, Net $149.0K $80.00K
YoY Change -5.1% -118.26%
Pretax Income -$1.112M $829.0K
YoY Change 3.44% -2.7%
Income Tax -$456.0K $200.0K
% Of Pretax Income 24.13%
Net Earnings -$656.0K $629.0K
YoY Change -38.0% 3.11%
Net Earnings / Revenue -1.27% 1.22%
Basic Earnings Per Share -$0.05 $0.05
Diluted Earnings Per Share -$0.05 $0.05
COMMON SHARES
Basic Shares Outstanding 12.71M shares 12.70M shares
Diluted Shares Outstanding 12.61M shares 13.11M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.33M $18.41M
YoY Change -0.22% 4.49%
Cash & Equivalents $17.33M $18.41M
Short-Term Investments
Other Short-Term Assets $3.789M $5.140M
YoY Change 16.44% 8.16%
Inventory $14.97M $15.71M
Prepaid Expenses
Receivables $2.335M $2.504M
Other Receivables $234.0K $150.0K
Total Short-Term Assets $38.66M $41.90M
YoY Change -12.84% -2.38%
LONG-TERM ASSETS
Property, Plant & Equipment $8.970M $9.310M
YoY Change -3.7% -0.99%
Goodwill
YoY Change
Intangibles $389.0K $422.0K
YoY Change -25.34% -23.83%
Long-Term Investments
YoY Change
Other Assets $518.0K $476.0K
YoY Change -62.35% -62.4%
Total Long-Term Assets $24.02M $24.70M
YoY Change 2.33% 0.11%
TOTAL ASSETS
Total Short-Term Assets $38.66M $41.90M
Total Long-Term Assets $24.02M $24.70M
Total Assets $62.68M $66.60M
YoY Change -7.59% -1.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.237M $6.763M
YoY Change -24.2% -13.8%
Accrued Expenses $15.96M $16.41M
YoY Change 5.62% 10.76%
Deferred Revenue $900.0K $1.000M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.02M $24.70M
YoY Change -1.36% 8.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $225.0K $151.0K
YoY Change -29.91% -49.5%
Total Long-Term Liabilities $225.0K $151.0K
YoY Change -29.91% -49.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.02M $24.70M
Total Long-Term Liabilities $225.0K $151.0K
Total Liabilities $35.38M $37.31M
YoY Change -1.56% 4.48%
SHAREHOLDERS EQUITY
Retained Earnings -$107.0M -$104.0M
YoY Change 7.38% 5.91%
Common Stock $135.5M $135.0M
YoY Change 2.23% 2.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.31M $29.29M
YoY Change
Total Liabilities & Shareholders Equity $62.68M $66.60M
YoY Change -7.59% -1.47%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$656.0K $629.0K
YoY Change -38.0% 3.11%
Depreciation, Depletion And Amortization $960.0K $918.0K
YoY Change -0.83% 9.16%
Cash From Operating Activities $1.752M $4.765M
YoY Change 81.18% -454.28%
INVESTING ACTIVITIES
Capital Expenditures $546.0K $1.133M
YoY Change -34.77% 55.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$546.0K -$1.133M
YoY Change -34.77% 55.85%
FINANCING ACTIVITIES
Cash Dividend Paid $5.534M
YoY Change 1367.9%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.542M -$6.668M
YoY Change 535.5% 1932.93%
NET CHANGE
Cash From Operating Activities 1.752M $4.765M
Cash From Investing Activities -546.0K -$1.133M
Cash From Financing Activities -2.542M -$6.668M
Net Change In Cash -1.336M -$3.200M
YoY Change 394.81% 24.47%
FREE CASH FLOW
Cash From Operating Activities $1.752M $4.765M
Capital Expenditures $546.0K $1.133M
Free Cash Flow $1.206M $3.632M
YoY Change 827.69% -275.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
168000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
465000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
795000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
126000 usd
CY2023Q3 us-gaap Dividends Cash
DividendsCash
5534000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-294000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
629000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
29294000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
31516000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
602000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
72000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
121000 usd
CY2022Q3 us-gaap Dividends Cash
DividendsCash
377000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-510000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
610000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31890000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
629000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
918000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
978000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
216000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1703000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1755000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
922000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1326000 usd
CY2023Q3 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-92000 usd
CY2022Q3 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1751000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-180000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2568000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
395000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-415000 usd
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-83000 usd
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3140000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
429000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1522000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-346000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
98000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2248000 usd
CY2023Q3 lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-243000 usd
CY2022Q3 lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-235000 usd
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
172000 usd
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-311000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4765000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1345000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1133000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
727000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1133000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-727000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
795000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
5534000 usd
CY2022Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
377000 usd
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
465000 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
72000 usd
CY2023Q3 lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
126000 usd
CY2022Q3 lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
121000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6668000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-328000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-164000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-171000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3200000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2571000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21605000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20190000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18405000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17619000 usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
168000 usd
CY2022Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
439000 usd
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America ("GAAP"). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div>
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-100000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
400000 usd
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12263000 usd
CY2023Q3 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.781
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12153000 usd
CY2023Q2 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.756
CY2023Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3443000 usd
CY2023Q3 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.219
CY2023Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3920000 usd
CY2023Q2 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.244
CY2023Q3 us-gaap Inventory Net
InventoryNet
15706000 usd
CY2023Q3 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2023Q2 us-gaap Inventory Net
InventoryNet
16073000 usd
CY2023Q2 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1300000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1300000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
800000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-200000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-100000 usd
CY2023Q3 lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
CY2023Q3 lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
CY2023Q3 lfvn Contracts With Customers Return Period For Resalable And Restockable Items
ContractsWithCustomersReturnPeriodForResalableAndRestockableItems
P12M
CY2023Q3 lfvn Contracts With Customers Refund Percent For Resalable And Restockable Items
ContractsWithCustomersRefundPercentForResalableAndRestockableItems
1
CY2023Q3 lfvn Handling And Restocking Fee Percentage
HandlingAndRestockingFeePercentage
0.10
CY2023Q3 lfvn Return Liability Reserve
ReturnLiabilityReserve
100000 usd
CY2023Q2 lfvn Return Liability Reserve
ReturnLiabilityReserve
100000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
629000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
610000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12537000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12457000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
572000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
38000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13109000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12495000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q3 lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 region
CY2023Q3 lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 region
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51364000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51774000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M10D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0317
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M7D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0325
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
600000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
530000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
671000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
48000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
27000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
12000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
590000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
721000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
557000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
755000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1502000 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1599000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1937000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1978000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2019000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2061000 usd
CY2023Q3 lfvn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
6394000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15988000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1868000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
14120000 usd
CY2022Q3 lfvn Debt Instrument Covenant Maximum Dividend
DebtInstrumentCovenantMaximumDividend
500000 usd
CY2023Q3 lfvn Debt Instrument Covenant Maximum Dividend
DebtInstrumentCovenantMaximumDividend
750000 usd
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 usd
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
60000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
100000 shares
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
800000 usd
CY2022Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
26100000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
20
CY2023Q3 lfvn Class Of Warrant Or Right Percent Of Common Stock Acquisition That Makes Rights Exercisable
ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisable
0.12
CY2023Q3 lfvn Class Of Warrant Or Right Percent Of Common Stock Acquisition That Makes Rights Exercisable Passive Investors
ClassOfWarrantOrRightPercentOfCommonStockAcquisitionThatMakesRightsExercisablePassiveInvestors
0.20
CY2023Q3 lfvn Class Of Warrants Or Right Discount
ClassOfWarrantsOrRightDiscount
0.50
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5500000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.435
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
400000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.03
CY2023Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
39000 shares
CY2022Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
36000 shares
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
600000 usd
CY2023Q3 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of September 30, 2023, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.

Files In Submission

Name View Source Status
lfvn-20230930_pre.xml Edgar Link unprocessable
lfvn-20230930_cal.xml Edgar Link unprocessable
0000849146-23-000204-index-headers.html Edgar Link pending
0000849146-23-000204-index.html Edgar Link pending
0000849146-23-000204.txt Edgar Link pending
0000849146-23-000204-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
leaseagreementshinagawag.htm Edgar Link pending
leaseagreementshinagawag001.jpg Edgar Link pending
leaseagreementshinagawag002.jpg Edgar Link pending
leaseagreementshinagawag003.jpg Edgar Link pending
leaseagreementshinagawag004.jpg Edgar Link pending
leaseagreementshinagawag005.jpg Edgar Link pending
leaseagreementshinagawag006.jpg Edgar Link pending
leaseagreementshinagawag007.jpg Edgar Link pending
leaseagreementshinagawag008.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
leaseagreementshinagawag009.jpg Edgar Link pending
leaseagreementshinagawag010.jpg Edgar Link pending
leaseagreementshinagawag011.jpg Edgar Link pending
leaseagreementshinagawag012.jpg Edgar Link pending
leaseagreementshinagawag013.jpg Edgar Link pending
leaseagreementshinagawag014.jpg Edgar Link pending
leaseagreementshinagawag015.jpg Edgar Link pending
leaseagreementshinagawag016.jpg Edgar Link pending
leaseagreementshinagawag017.jpg Edgar Link pending
leaseagreementshinagawag018.jpg Edgar Link pending
leaseagreementshinagawag019.jpg Edgar Link pending
leaseagreementshinagawag020.jpg Edgar Link pending
leaseagreementshinagawag021.jpg Edgar Link pending
lfvn-20230930.htm Edgar Link pending
lfvn-20230930.xsd Edgar Link pending
lfvn_093023xex311.htm Edgar Link pending
lfvn_093023xex312.htm Edgar Link pending
lfvn_093023xex321.htm Edgar Link pending
lfvn_093023xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
lfvn-20230930_def.xml Edgar Link unprocessable
lfvn-20230930_lab.xml Edgar Link unprocessable
lfvn-20230930_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending